YESID ALVARADO to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications YESID ALVARADO has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.058
-
Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality. Am J Hematol. 2021 03 01; 96(3):282-291.
Score: 0.039
-
Long-term prognostic impact of the use of erythropoietic-stimulating agents in patients with chronic myeloid leukemia in chronic phase treated with imatinib. Cancer. 2011 Mar 01; 117(5):982-91.
Score: 0.019